- Catholic Health (Roslyn, NY)
- …accolades and rankings that underscore its commitment to excellence in cardiovascular care and overall hospital performance. Accreditations and Ratings: - STS ... US News & World Report Rankings: - Top-Rated in Cardiovascular Surgery and Cardiology: SFH consistently ranks among the...ranks among the top hospitals in the nation for cardiovascular surgery and cardiology according to US News &… more
- Cipla (Hauppauge, NY)
- …with focus on a range of therapeutic areas, including cardiovascular , anti-infective, CNS, anti-inflammatory, anti-diabetic, and anti-depressants. The company was ... founded in 2003 and is based in Central Islip and Hauppauge, New York. As of February 18, 2016, InvaGen Pharmaceuticals, Inc. operates as a subsidiary of Cipla (EU) Limited. more
- Optum (Middletown, NY)
- …team-based care environment Offices offer a broad array of cardiovascular services: exercise stress testing, non-invasive imaging, echocardiogram and vascular ... of (NY) at time of employment Board Certification or Board Eligibility in Cardiovascular Disease Active and unrestricted DEA license or ability to obtain prior to… more
- Daiichi Sankyo, Inc. (Chicago, IL)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary:The District Manager (DM) represents… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: The Senior Director, Clinical Safety, will lead… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. SummaryThe Director Global Medical Affairs Oncology… more
- Cipla (Fall River, MA)
- …with focus on a range of therapeutic areas, including cardiovascular , anti-infective, CNS, anti-inflammatory, anti-diabetic, and anti-depressants. The company was ... founded in 2003 and is based in Central Islip and Hauppauge, New York. In October 2020, InvaGen established its project site in Fall River, Massachusetts to support the launch of Cipla's respiratory business in the United States. EQUAL OPPORTUNITY EMPLOYER… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: Accountable to organize and directs an audit… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. SummaryMedical Affairs Diagnostic lead, under leadership… more
- Cipla (Fall River, MA)
- …with focus on a range of therapeutic areas, including cardiovascular , anti-infective, CNS, anti-inflammatory, anti-diabetic, and anti-depressants. The company was ... founded in 2003 and is based in Central Islip and Hauppauge, New York. As of February 18, 2016, InvaGen Pharmaceuticals, Inc. operates as a subsidiary of Cipla (EU) Limited. more
